BRCA2 and ovarian small cell carcinoma: Yaghmour et al. analyzed the data of 46 patients with neuroendocrine cancers of the ovary, including 10 with small cell carcinoma of the ovary, and found that actionable mutations were rare; only one of the patients with small cell carcinoma of the ovary had a somatic BRCA2 mutation.